New drug cocktail aims to wipe out breast cancer before surgery
Disease control
Recruiting now
This study tests whether giving a combination of three drugs (neratinib, an aromatase inhibitor, and trastuzumab) for 24 weeks before surgery can eliminate all signs of cancer in the breast tissue of people with ER-positive, HER2-positive breast cancer. About 30 postmenopausal wo…
Phase: PHASE2 • Sponsor: Ruth O'Regan • Aim: Disease control
Last updated May 15, 2026 11:54 UTC